Leica Microsystems enter worldwide collaboration on RNA ISH analysis Affymetrix.

George Bers, Vice President and General Manager of Expression Business Unit – Panomics at Affymetrix says that: ‘We are excited by this partnership with Leica as it unlocks the real potential of single-copy RNA evaluation and we believe it will accelerate the discovery of essential new medications and the validation of novel companion testing.’ Arnd Kaldowski, President of Leica Biosystems, agrees saying ‘While medical science has created powerful new remedies that greatly enhance lives, there are numerous disease states where we have to discover better treatments still, or even cures.The patients we evaluated represented 25 percent of total hospitalizations for 2009 H1N1 an infection which were reported to the CDC through the surveillance period that finished on June 9, 2009, and they represented the majority of the continuing states with substantial influenza outbreaks throughout that period. Participation in the analysis was voluntary and was therefore at the mercy of reporting bias. We evaluated only patients with confirmed 2009 H1N1 infection, therefore the group may not be representative of hospitalized patients who may not have been tested.